Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-30 @ 4:40 PM
Study NCT ID:
NCT05697003
Status:
UNKNOWN
Last Update Posted:
2023-03-09
First Post:
2023-01-10
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bioequivalence Study for Fluticasone Propionate 100 mcg/Salmeterol Xinafoate 50 mcg Inhalation Powder in Healthy Volunteers
Sponsor:
Respirent Pharmaceuticals Co Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-02-17
Start Date Type:
ACTUAL
Primary Completion Date:
2023-03-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2023-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2023-01-10
First Submit QC Date:
None
Study First Post Date:
2023-01-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-03-08
Last Update Post Date:
2023-03-09
Last Update Post Date Type:
ACTUAL